Immune disease comorbidities

No definition available.

Endpoint definition

FinnGen phenotype data

Filter registries None

Check pre-conditions None

Check conditions None

Apply sex-specific rule None

diagram downward connector ASTHMA_IMMUNECOMORB

Extra metadata

First used in FinnGen datafreeze DF2

Summary Statistics

Key figures

All Female Male
Number of individuals 23697 15204 8493
Unadjusted prevalence (%) 9.11 10.35 7.51
Mean age at first event (years) 48.49 47.52 50.23

Mortality

Follow-up Absolute risk HR [95% CI] p N
1998–2019 0.03 2.10 [1.80, 2.44] 4.0e-21 2434
15 years 0.02 2.36 [2.07, 2.68] 2.0e-38 1972
5 years 0.00 4.01 [3.57, 4.51] <1e-100 911
1 year 0.00 6.64 [5.60, 7.87] <1e-100 299

Correlations

Index endpoint: ASTHMA_IMMUNECOMORB – Immune disease comorbidities
GWS hits:

Survival analyses between endpoints

Plot

before Immune disease comorbidities
after Immune disease comorbidities

loading spinner Loading survival analyses plot

Drugs most likely to be purchased after Immune disease comorbidities